A detailed history of Concord Wealth Partners transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 63 shares of SLP stock, worth $1,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63
Previous 63 -0.0%
Holding current value
$1,786
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$37.48 - $44.74 $2,361 - $2,818
63 New
63 $2,000
Q2 2022

Aug 04, 2022

SELL
$40.55 - $51.76 $32,358 - $41,304
-798 Reduced 92.36%
66 $3,000
Q1 2022

Apr 20, 2022

SELL
$36.56 - $50.98 $1,279 - $1,784
-35 Reduced 3.89%
864 $44,000
Q4 2021

Jan 21, 2022

BUY
$37.1 - $57.45 $28,752 - $44,523
775 Added 625.0%
899 $43,000
Q3 2021

Nov 09, 2021

BUY
$38.45 - $55.66 $3,652 - $5,287
95 Added 327.59%
124 $5,000
Q2 2021

Jul 29, 2021

BUY
$49.67 - $68.96 $1,440 - $1,999
29 New
29 $2,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $575M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.